triiodothyronine has been researched along with Hepatoblastoma in 5 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Co-incubating 0-10 nmol/l T3 with 100 nmol/l insulin resulted in a downward shift in the dose-response curve without a change in the half-maximal response to T3." | 1.30 | Modulation of T3-induced sex hormone-binding globulin secretion by human hepatoblastoma cells. ( Barlow, JW; Lim, CF; Loidl, NM; Payne, KL; Stockigt, JR; Topliss, DJ, 1997) |
| "Treatment of two acute promyelocytic leukemia patients with ATRA induced maximal 2." | 1.29 | An in vitro system for identifying agents capable of changing serum lipoprotein(a) concentration by regulating the transcriptional activity of the apolipoprotein(a) gene promoter. ( Azuma, H; Kanagawa, Y; Mima, N; Miyamoto, K; Saito, S; Shigekiyo, T; Shirakawa, M; Watanabe, A; Yamaguchi, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moriyama, K | 1 |
| Tagami, T | 1 |
| Akamizu, T | 1 |
| Usui, T | 1 |
| Saijo, M | 1 |
| Kanamoto, N | 1 |
| Hataya, Y | 1 |
| Shimatsu, A | 1 |
| Kuzuya, H | 1 |
| Nakao, K | 1 |
| Crowe, TC | 1 |
| Cowen, NL | 1 |
| Loidl, NM | 3 |
| Topliss, DJ | 3 |
| Stockigt, JR | 3 |
| Barlow, JW | 3 |
| Raggatt, LE | 1 |
| Scholz, GH | 1 |
| Blok, RB | 1 |
| Azuma, H | 1 |
| Yamaguchi, H | 1 |
| Mima, N | 1 |
| Shirakawa, M | 1 |
| Miyamoto, K | 1 |
| Kanagawa, Y | 1 |
| Watanabe, A | 1 |
| Shigekiyo, T | 1 |
| Saito, S | 1 |
| Payne, KL | 1 |
| Lim, CF | 1 |
5 other studies available for triiodothyronine and Hepatoblastoma
| Article | Year |
|---|---|
Thyroid hormone action is disrupted by bisphenol A as an antagonist.
Topics: Animals; Benzhydryl Compounds; Cell Nucleus; DNA-Binding Proteins; Gene Expression; Glycoprotein Hor | 2002 |
Down-regulation of thyroxine-binding globulin messenger ribonucleic acid by 3,5,3'-triiodothyronine in human hepatoblastoma cells.
Topics: Cell Line; Gene Expression Regulation, Neoplastic; Hepatoblastoma; Humans; Kinetics; Liver Neoplasms | 1995 |
Preferential inhibition of cytoplasmic T3 binding is associated with reduced nuclear binding in cultured cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Cells, Cultured; Cytoplasm; Diclofenac; Hepat | 1996 |
An in vitro system for identifying agents capable of changing serum lipoprotein(a) concentration by regulating the transcriptional activity of the apolipoprotein(a) gene promoter.
Topics: Adult; Apolipoproteins; Apoprotein(a); Base Sequence; Cell Line; Danazol; DNA; DNA Primers; Female; | 1996 |
Modulation of T3-induced sex hormone-binding globulin secretion by human hepatoblastoma cells.
Topics: Butyrates; Butyric Acid; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Hepatobla | 1997 |